Connect with us

Technology

CIRO Hearing Panel issues Reasons for Decision in the matter of Graham Darren Moore

Published

on

VANCOUVER, BC, Feb. 27, 2024 /CNW/ – Following a settlement hearing held pursuant to the Investment Dealer and Partially Consolidated Rules on February 9, 2024, in Vancouver, British Columbia, a hearing panel of the Canadian Investment Regulatory Organization (CIRO) found that Graham Darren Moore failed to fulfill his gatekeeper responsibilities, accepted trading instructions from a person who was not authorized in writing to provide such instructions, and communicated with clients using an unapproved third-party communication application.

The hearing panel issued its reasons for decision on February 16, 2024, which are available at:

Re Moore, 2024 CIRO 26

In its reasons for decision, the hearing panel confirmed its earlier acceptance of the settlement agreement and the penalties, including a reprimand and payment of costs in the amount of $7,500.

The alleged violations occurred while Graham Darren Moore was a Registered Representative with the Vancouver branch of Haywood Securities Inc., where he continues to be employed in a registered capacity.

All information about disciplinary proceedings relating to current and former member firms and individual registrants under the Investment Dealer and Partially Consolidated Rules (for investment dealers), the Mutual Fund Dealer Rules (for mutual fund dealers) and the Universal Market Integrity Rules (UMIR) is available on CIRO’s website

Background information regarding the qualifications and disciplinary history, if any, of advisors currently employed by CIRO-regulated investment firms is available free of charge through the AdvisorReport service. Information on how to make dealer, advisor or marketplace-related complaints is available by calling 1-877-442-4322.

CIRO investigates possible misconduct by its member firms and individual registrants. It can bring disciplinary proceedings which may result in sanctions including fines, suspensions, permanent bars, expulsion from membership, or termination of rights and privileges for individuals and firms.

The Canadian Investment Regulatory Organization (CIRO) is the national self-regulatory organization that oversees all investment dealers, mutual fund dealers and trading activity on Canada’s debt and equity marketplaces. CIRO is committed to the protection of investors, providing efficient and consistent regulation, and building Canadians’ trust in financial regulation and the people managing their investments. For more information, visit www.ciro.ca.

SOURCE Canadian Investment Regulatory Organization (CIRO)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

Published

on

By

News Summary 

Saves up to six months on compliant software validation in biopharmaceutical quality control.1Reduces analysis time for biotherapeutic peptides and proteins by 20%.2Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques.3

MILFORD, Mass., May 13, 2025 /PRNewswire/ — Waters Corporation (NYSE:WAT) today announced that its Empower™ Software now supports biologics data acquisition and quality control (QC) analysis from Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments in its Wyatt Technology™ Portfolio. This integration expands the scope of critical quality attributes that a biopharmaceutical laboratory can manage using Empower Software. Additionally, this advancement will simplify the process and digital footprint of acquiring and submitting compliant data to regulatory authorities – from biologics development through QC – saving customers up to six months of software validation time.

Empower Software is the industry’s most established and compliant-ready chromatography data system (CDS), widely adopted globally and used to submit data for more than 80% of novel drugs to regulatory authorities.4 The new integration unlocks the ability to use MALS techniques in quality control for biotherapeutics, improving efficiency and Good Manufacturing Practices (GMP) readiness, while reducing end-user training in compliant settings.

“Today’s launch of Empower for Multi-Angle Light Scattering Detectors underscores our commitment from the Wyatt acquisition to integrate advanced analytical technologies into our Empower CDS ecosystem,” said Dr. Udit Batra, President & CEO, Waters Corporation. “Specifically, MALS supported on Empower Software reveals high molecular weight species that are not visible to other detectors – reducing the risk of erroneous results in biotherapeutic quality control. By combining the strengths of compliant software with deep analytical light scattering instrumentation, we are providing customers with a unified solution that enhances productivity and data accuracy – ultimately supporting high-volume QC testing to ensure the safety of life-saving biologic therapies for patients.”

The integration of the DAWN™, miniDAWN™, and OptiLab™ Detectors will enable the measurement of more critical quality attributes of peptides and proteins in a single run, reducing analysis time by 20% and providing earlier insights into the stability, safety, and efficacy of biologics.

“As a Contract Development and Manufacturing Organization (CDMO), we anticipate that MALS on Empower Software will enhance our service offerings,” said William Wittbold, Senior Director of Operations, at Pace Analytical. “The detailed MALS data is essential for understanding complex biotherapeutics. Combined with the reliability of Empower Software, we believe this integration will deliver exceptional value to our customers, ensuring our drug development partners receive the highest quality results.”

The capability to integrate the DAWN, miniDAWN, and OptiLab Detectors with Empower Software will be available for peptide and protein workflows in July 2025. Learn more by visiting our product page

Additional Resources

     –       Learn more about the MALS integration with Empower Software.
     –       Follow and connect with Waters LinkedInTwitter, and Facebook.

ABOUT: Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science.

Waters, Empower, DAWN, miniDAWN, OptiLab, and Wyatt Technology are trademarks of Waters Technologies Corporation.

Contact:

Molly Gluck
Head of External Communications
Waters Corporation
molly_gluck@waters.com
Mobile: +1.617.833.8166

1. In a recent survey of 50 MALS users, responding to the question “How long does it typically take you to validate new software in a GxP lab,” the average time was reported as 6 months since it is one software instead of two.

2. In a recent survey of 50 MALS users, responding to the question “How much time, as a percentage of total working time, would you save on average if you could use your primary CDS software (LC software) for MALS data analysis,” the average time saving was reported as 20%.

3. White paper WP1615: “SEC-MALS for absolute biophysical characterization” describes the challenges associated with determining basic physical properties of biologics in solution, and provides examples of how multi-angle light scattering can reduce the occurrence of erroneous results prevalent in relative measurement techniques. MALS provides absolute results from first principles, avoiding errors of relative measures, and is independent of retention time, reference materials, and column interactions.

4. Presented at the J.P. Morgan 43rd Annual Healthcare Conference. According to internal analysis, ~80% of the drugs filed with the FDA, EMA, and China National Medical Products Administration (NMPA) in 2023 were done so using Empower Software. Source: Waters data and estimates.

 

View original content:https://www.prnewswire.com/apac/news-releases/waters-integrates-multi-angle-light-scattering-detectors-with-empower-software-for-improved-biologics-quality-control-and-simplified-regulatory-compliance-302452780.html

SOURCE Waters Corporation

Continue Reading

Technology

Razor Labs Launches DataMind AI™ 4.1

Published

on

By

Razor Labs Launches DataMind AI™ 4.1: Unlocking Faster, Smarter Predictive Maintenance for Mining Operations

SYDNEY, May 13, 2025 /PRNewswire/ — Razor Labs (TASE: RZR), a leader in AI-driven predictive maintenance, proudly announces the release of DataMind AI™ Version 4.1. This major update delivers groundbreaking innovations that accelerate real-time decision-making, strengthen diagnostic power, and transform maintenance workflows for mining and industrial teams.

DataMind AI™ 4.1 is built to meet the growing operational demands of heavy industry environments, helping maintenance teams protect critical assets, optimize performance, and reduce unplanned downtime.

“Version 4.1 represents a major leap forward in empowering maintenance teams with the tools they need to act faster, intervene smarter, and achieve operational excellence,” said Raz Roditti, CEO of Razor Labs. “We remain committed to delivering practical, high-impact innovations that transform maintenance strategies across the mining sector.”

“Every feature in Version 4.1 is designed with a singular focus: empowering reliability and maintenance experts to achieve faster insights, better decisions, and earlier interventions,” added Assaf Eden, VP of Product at Razor Labs. “We are pushing the boundaries of predictive maintenance, making it simpler, smarter, and more aligned with real-world operational needs.”

Key Innovations in DataMind AI™ 4.1

Instant Asset Health Insights: Revolutionary Health Status Cards provide immediate visibility into equipment conditions, empowering proactive maintenance actions that prevent costly failures.Streamlined Maintenance Tracking: An enhanced Maintenance Data Table centralizes work orders, asset health, and maintenance scheduling into a single, intuitive hub, simplifying operations across teams.Sharper Asset Prioritization: Powerful Site and Asset Filters enable faster, risk-based targeting of critical assets requiring urgent attention, boosting maintenance efficiency and focus.Faster, Smoother Workflows: A fully upgraded interface accelerates workflows from diagnostics to intervention, reducing operational friction and enabling faster response times.Enhanced Diagnostic Power: A new Oil Report Add-On, developed specifically for reliability experts, strengthens DataMind AI™’s advanced sensor fusion analytics, catching hidden lubrication-related risks before they escalate into costly failures.

DataMind AI™’s predictive insights have already helped leading mining operations prevent equipment failures and optimize asset performance, demonstrating measurable real-world impact.

DataMind AI™ 4.1 will also be showcased at GRX 2025, the global mining event held May 20–25, 2025, in Brisbane, Australia.

About Razor Labs

Razor Labs (TASE: RZR) is a global leader in mining technology, specializing in predictive maintenance solutions that combine advanced AI Sensor Fusion with real-time diagnostics. With operations across Australia, South Africa, the United States, and Colombia, Razor Labs helps critical industries transform asset reliability, efficiency, and safety.

Learn more: www.razor-labs.com
Follow us on LinkedIn: https://www.linkedin.com/company/razor-technologies-inc 

Subscribe to our YouTube Channel: https://www.youtube.com/@RazorLabsAI 

Media Inquiries:
Liel Anisenko, Director of Marketing
Phone: +61.488.860.440
Email: pr@www.razor-labs.com

View original content:https://www.prnewswire.com/apac/news-releases/razor-labs-launches-datamind-ai-4-1–302452716.html

SOURCE Razor Labs

Continue Reading

Technology

1Q25 Results: Telefônica Brasil S.A.

Published

on

By

SÃO PAULO, May 12, 2025 /PRNewswire/ — Telefônica Brasil – (B3: VIVT3; NYSE: VIV) announces its results for 1Q25.

Strong operating performance led to robust EBITDA and net income growth.

R$ million

1Q25 

 1Q24

% YoY

Net Operating Revenue

14,390

13,546

6.2

Mobile Services

9,272

8,702

6.5

FTTH

1,899

1,717

10.6

Corporate Data, ICT and Digital Services

1,312

1,132

15.8

Handsets and Electronics

909

881

3.2

Other Revenues¹

999

1,114

(10.3)

Total Costs

(8,687)

(8,269)

5.1

EBITDA

5,704

5,277

8.1

EBITDA Margin

39.6 %

39.0 %

0.7 p.p.

EBITDA AL²

4,376

4,047

8.1

EBITDA AL² Margin

30.4 %

29.9 %

0.5 p.p.

Net Income

1,058

896

18.1

Earnings per Share (EPS)

0.65

0.54

20.3

CAPEX ex-IFRS 16

1,869

1,874

(0.3)

Operating Cash Flow (OpCF)

3,835

3,403

12.7

OpCF Margin

26.7 %

25.1 %

1.5 p.p.

Operating Cash Flow AL (OpCF AL)²

2,508

2,173

15.4

OpCF AL² Margin

17.4 %

16.0 %

1.4 p.p.

Free Cash Flow

2,124

2,380

(10.7)

Total Subscribers (Thousand)

116,127

113,481

2.3

1 Other Revenues include Voice, xDSL, FTTC and IPTV. 2 AL means After Leases.

Net revenue expanded by +6.2% YoY, driven by the strong performance of postpaid (+10.3% YoY) and fiber (+10.6% YoY) revenues. Postpaid’s performance is supported by the increase in the customer base (+7.7% YoY), that ended the quarter with 67.4 million accesses due to significant migrations and the acquisition of new customers. Additionally, the impact of annual price adjustments contributed to the +2.0% YoY increase in postpaid ARPU, excluding M2M and dongles, reaching R$52.2.

Fixed revenue increased +6.2% YoY, supported by strong growth in FTTH (+10.6% YoY) and Corporate Data, ICT, and Digital Services revenues (+15.8% YoY) in 1Q25. Our FTTH network reached 29.6 million homes passed (+10.5% YoY), with 7.2 million homes connected (+12.9% YoY).

EBITDA grew by +8.1% YoY, with a margin of 39.6%, an increase of +0.7 p.p. in the annual comparison. EBITDA AL also expanded by +8.1% YoY, with a margin of 30.4% (+0.5 p.p. YoY).

In 1Q25, Capex totaled R$1,869 million, a decrease of -0.3% YoY, representing 13.0% of revenues (-0.9 p.p. YoY), reflecting the reduction in Capex intensity over net revenue. Investments were directed towards strengthening our 5G network, which is already present in 519 cities (+2.9x YoY), covering 62% of the Brazilian population, and expanding our fiber operation.

Operating Cash Flow totaled R$3,835 million (+12.7% YoY), with a margin of 26.7% (+1.5 p.p. YoY) over net revenue.

Net income attributed to Telefônica Brasil reached R$1,058 million in the quarter, an increase of +18.1% YoY. The remuneration paid to shareholders totaled R$2,576 million by the end of April 2025. Additionally, on July 15, 2025, we will pay R$2,000 million related to the second capital reduction event. The Company has just deliberated an additional R$500 million in interest on equity, totaling R$1,120 million up to May 2025. We committed to distribute to our shareholders an amount equal to or greater than 100% of net income for each fiscal year from 2024 to 2026. In 2024, we met the guidance, with a payout of 105.3% of net income.

TELEFÔNICA BRASIL – Investor Relations

ir.br@telefonica.com 
To download the complete version of the Company’s earnings release, please visit our website: https://ri.telefonica.com.br/en 

View original content:https://www.prnewswire.com/news-releases/1q25-results-telefonica-brasil-sa-302453046.html

SOURCE Telefônica Brasil S.A.

Continue Reading

Trending